Excellent short-term CD4 recovery with a PI- and NRTI-sparing regimen in triple-class failure HIV-infected patients: raltegravir, maraviroc, etravirine

Nozza, S; Visco, F; Soria, A; Galli, L; Salpietro, S; Gianotti, N; Carini, E; Bigoloni, A; Fusetti, G; Tambussi, G; Lazzarin, A; Castagna, A

doi:10.1186/1758-2652-11-S1-P45

Journal of the International AIDS Society

Article metrics
Last updated: Wed, 24 Apr 2024 6:30:46 Z

Excellent short-term CD4 recovery with a PI- and NRTI-sparing regimen in triple-class failure HIV-infected patients: raltegravir, maraviroc, etravirine

Access & Citations

1234

Article Accesses
0

Web of Science
4

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.